Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Sanofi India Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cross sectional phase - All male and female adults (with lower legal age limitations (country specific) diagnosed with type 1 or type 2 diabetes, visiting the physician during the recruitment period of the cross-sectional study, up to the number of patients allocated to the physician. - Written informed consent 2. Longitudinal phase - Each patient will be asked to enter into the 9-month follow-up period
Exclusion criteria
Exclusion criteria: 1. Cross sectional phase - Concomitant participation in a clinical trial. - Current temporary insulin therapy (eg, gestational diabetes, surgery, pancreas cancer) 2. Longitudinal phase - Concomitant participation in clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The global proportion of patients with T2DM treated with insulinTimepoint: 9 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The management of care of patients with type 2 diabetes (T2DM) (CS) will be illustrated by: 1. The proportion of T2DM patients achieving glycemic targets (HbA1c) as per recommendations of International guidelines and as targeted by the treating physician. Timepoint: 9 Months | — |
Countries
India
Contacts
Public ContactMs Vaishali Kanade
Sanofi India Limited
Outcome results
None listed